PainChek Limited (ASX:PCK)

Australia · Delayed Price · Currency is AUD

0.1000

-0.0050 (-4.76%)

Jul 29, 2026, 4:15 PM AEST

-72.97% (1Y)

Market Cap	21.95M -70.2%
Revenue (ttm)	3.44M +13.6%
Net Income	-9.22M
EPS	-0.05
Shares Out	209.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	361,305
Open	0.1050
Previous Close	0.1050
Day's Range	0.1000 - 0.1070
52-Week Range	0.0950 - 1.0500
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About PainChek

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company offers PainChek, a clinically validated and regulatory cleared pain assessment technology that uses cameras in smartphones for a facial scan that is analyzed using facial recognition software to indicate the presence of pain. It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant s... [Read more]

Industry Health Information Services

Sector Healthcare

CEO Philip Daffas

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol PCK

Full Company Profile

Financial Performance

In fiscal year 2025, PainChek's revenue was 3.36 million, an increase of 25.84% compared to the previous year's 2.67 million. Losses were -7.67 million, -7.65% less than in 2024.

Financial Statements